Search results
3 Blue-Chip Stocks Set to Triple Soon
InvestorPlace via Yahoo Finance· 7 days agoInvestors should have a wide range of companies in multiple sectors within their investment portfolio. But the backbone of any resilient portfolio that...
Hims & Hers is now selling Ozempic-like weight loss drugs for $199
Quartz· 7 days agoThe millennial-skewed telehealth platform Hims & Hers announced Monday that is now offering...
3 Blue-Chip Stocks to Buy on the Dip: May 2024
InvestorPlace· 6 days agoWhile the latest Commerce Department report showed a notable deceleration in GDP growth, experts attribute much of this to robust spending on imported...
The Savvy Investor's Cheat Sheet: 3 Deep Value Picks for May 2024
InvestorPlace· 4 days agoChubb Limited (NYSE:CB) is an insurance firm that was spotlighted when it was revealed that...
Experts Predict Rise In COVID-19 Cases: Vaccine Stocks Climb - Moderna (NASDAQ:MRNA)
Benzinga· 5 days agoShares of vaccine producers' stocks are trading higher Wednesday on reports indicating disease...
AstraZeneca (AZN) to Build $1.5B Cancer Drug Plant in Singapore
Zacks via Yahoo Finance· 7 days agoThis new plant will be AstraZeneca's (AZN) first manufacturing facility for producing novel antibody...
GSK’s New Vaccine Kept the Boss in Her Job — and an Activist at Bay
Bloomberg via Yahoo Finance· 6 days ago(Bloomberg) -- When Elliott Investment Management came calling for the ouster of Emma Walmsley, the...
AstraZeneca sets bold revenue target as CEO aims to double sales to $80 billion by 2030
Fortune· 6 days agoThe company, which generated $45.8 billion in revenue last year, will launch 20 new medicines by the end of the decade to meet the new total revenue target, Astra said Tuesday. The revenue goal ...
Guardant Health Rises On A Key Colon Cancer Win; Exact Sciences Dips
Investor's Business Daily· 3 days agoThe FDA's Medical Devices Advisory Committee voted eight to one that Guardant's blood-based test,...
5 Undervalued Stocks That Crushed Earnings for Q1 2024
Morningstar· 4 days agoCombining the results of firms in the Morningstar US Market Index that have reported earnings with...